Visit Health is a healthtech startup based in the Delhi NCR (Noida) region of India that provides outpatient (OPD) and wellness benefit plans for employers and their employees.

This Startup Deep Dive explains what Visit Health does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Visit Health in Brief

• What it is: Visit Health is an Indian Employee OPD and wellness company based in Noida.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Visit Health sells tailored subscription plans for wellness and OPD services, paid for by employers, with employees and their families as beneficiaries.
• Company-stated: it serves over 400 large companies, more than 4,500 small businesses and 15 insurers.
• The 2024 round included a partnership with TatvaCare.
• Funding: Reported: about $37.5 million across 5 rounds.

Visit Health Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Visit Health?

Visit Health operates in the Employee OPD and wellness space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Visit Health.

• Visit Health sells tailored subscription plans for wellness and OPD services, paid for by employers, with employees and their families as beneficiaries.
• Company-stated: it serves over 400 large companies, more than 4,500 small businesses and 15 insurers.
• The 2024 round included a partnership with TatvaCare.

The Origin Story of Visit Health

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Vaibhav Singh, Shashvat Tripathi, Chetan Anand, Anurag Prasad.
• The founders are BITS Pilani alumni; sources differ on whether the company started in 2015 or 2016.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Employee OPD and wellness sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• October 2021: reported about $7.5 million investment from Docprime Technologies (a PB Fintech subsidiary).
• August 2024: reported INR 250 crore round, along with a second ESOP buyback.

Visit Health Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Reported: about $7.5 million from Docprime in October 2021; other investors include MapmyIndia, Kunal Bahl, Rohit Bansal and Murali Krishna.
• Reported: about INR 250 crore in 2024 with primary and secondary components; Docprime was among the sellers.

How Does Visit Health Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Employers pay subscription fees for OPD and wellness plans for their staff.

The Numbers: Visit Health Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• Reported: FY24 revenue about Rs 131.1 crore, up from Rs 53.5 crore in FY23.
• Reported: FY24 profit after tax of Rs 66 lakh. Company-stated: EBITDA positive.

Market Opportunity for Visit Health

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Demand drivers: rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings.
• Reach: How much of the market Visit Health can serve depends on its product readiness, distribution and regulatory approvals.

Technology and Product at Visit Health

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Core capability: Public detail on Visit Health’s technology stack is limited beyond company-stated descriptions.
• Assessment lens: clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

Team and Culture at Visit Health

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Leadership: Vaibhav Singh, Shashvat Tripathi, Chetan Anand, Anurag Prasad are named as founders.
• Further detail on the wider team is limited in public sources.

Visit Health Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

• Direct competitors of Visit Health vary by product line; a verified rival comparison was not available from public sources.
• What to compare: Product readiness, pricing, customer base, funding runway and regulatory standing.

Risks and Challenges for Visit Health

• One data provider shows a very different 2023 revenue figure, so financial data differ between sources.
• Reported thin net margin of about 0.5% in FY24.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.
• Data privacy risk: health records are sensitive, and breaches or misuse can bring legal and reputational harm.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Visit Health Growth Outlook: What to Watch

• Reported: the 2024 funds are meant to expand business operations, including the TatvaCare partnership.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Visit Health can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Visit Health Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Visit Health

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Visit Health.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Visit Health

Studying a company in the Employee OPD and wellness space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Visit Health.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Visit Health as a Startup

• Customer clarity: Can Visit Health name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Visit Health is part of India’s growing Employee OPD and wellness ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Visit Health FAQs: Frequently Asked Questions

What is Visit Health?

Visit Health is a healthtech startup based in the Delhi NCR (Noida) region of India that provides outpatient (OPD) and wellness benefit plans for employers and their employees. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Visit Health?

Visit Health was founded by Vaibhav Singh, Shashvat Tripathi, Chetan Anand, Anurag Prasad, and the company reports a founding year of 2015 or 2016 (reports differ).

How much funding has Visit Health raised?

Reported: about $37.5 million across 5 rounds. Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Visit Health make money?

Visit Health earns revenue from its Employee OPD and wellness products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Visit Health?

Competitors of Visit Health depend on the specific product line. A verified comparison was not available, so see the evaluation checklist above.

What are the main risks for Visit Health?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: OrbitAID Aerospace — Indian startup building satellite refuelling ports | Mykare Health — Mykare Health: $2.01M seed for affordable surgery access. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.